Leap Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
CYPH
CUSIP
52187K200
Type
Equity
Class
COM NEW
Num filings
61
Total reported value, excl. options
$55.3 M
Manager Report Date Value ($000) Shares Option Type